sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling
about
The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionAcute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.Fractalkine depresses cardiomyocyte contractilityDynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function.Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial.The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.Inhalative and intravenous stimulation of soluble guanylate cyclase reduces pulmonary vascular resistance and increases cardiac output in experimental septic shock.Nitric Oxide Regulates Skeletal Muscle Fatigue, Fiber Type, Microtubule Organization, and Mitochondrial ATP Synthesis Efficiency Through cGMP-Dependent Mechanisms.Regulation of Calcium-Independent Phospholipase A2 Expression by Adrenoceptors and Sterol Regulatory Element Binding Protein-Potential Crosstalk Between Sterol and Glycerophospholipid Mediators.Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.Newly Identified NO-Sensor Guanylyl Cyclase/Connexin 43 Association Is Involved in Cardiac Electrical Function.Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.
P2860
Q27024279-977C5A47-4B8D-4A4B-A6E9-1ED86D1CA2C9Q34448355-8FB685C3-F0C0-423F-B28B-C2D6F6A538C3Q34921351-E7E9BF6D-1AFD-4841-A5FA-81432EB9D857Q35837215-6674F897-092C-4B18-BEB5-5AC5FC1BE00DQ37510689-77E7148F-3238-4A99-A471-06BFDF66D276Q37665613-1B117749-9147-48ED-8E8E-6A16907686C7Q37734554-B6548EE9-28A8-486A-B784-D466247DD51EQ38412804-55A87C4E-6ACA-428A-B1E2-6B75A2261615Q38931646-14AB2CB0-48BC-4BBC-B51C-474FA0C371D4Q45418272-AAEAD8D4-D8F9-48F3-9246-4F59CC7F589EQ47263257-57AE4B1F-23F7-4B9A-AA94-78A9D82B7C93Q48640874-35AA3C93-7781-4850-A1DA-A590640F38BDQ52375176-593C8946-6641-494C-BF0D-207E02CFE923
P2860
sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@ast
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@en
type
label
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@ast
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@en
prefLabel
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@ast
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@en
P2093
P2860
P1476
sGC{alpha}1 mediates the negat ...... of changes in calcium handling
@en
P2093
Emmanuel S Buys
Fumito Ichinose
Kenneth D Bloch
Peter Brouckaert
Sharon M Cawley
Starsha Kolodziej
P2860
P304
P356
10.1152/AJPHEART.01273.2010
P577
2011-05-02T00:00:00Z